House Ag chairman was among investors in Innate Immunotherapeutics
In early 2017, House Agriculture chairman Michael Conaway was among U.S. representatives who purchased stock in the Australian biomedical company that's at the center of insider-trading charges against New York Rep. Chris Collins. The comparatively wealthy Conaway bought shares of Innate Immunotherapeutics in January and February 2017 through a Merrill Lynch account that he owns jointly with a family member, said the good-government group Citizens for Responsibility and Ethics in Washington (CREW).